Missing-view completion for fatty liver disease detection.

Comput Biol Med

PAMI Research Group, Dept. of Computer and Information Science, University of Macau, Macau, China; Beijing Key Laboratory of Big Data Technology for Food Safety, Beijing Technology and Business University, Beijing, China. Electronic address:

Published: November 2022


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Fatty liver disease is a common disease that causes extra fat storage in an individual's liver. Patients with fatty liver disease may progress to cirrhosis and liver failure, further leading to liver cancer. The prevalence of fatty liver disease ranges from 10% to 30% in many countries. In general, detecting fatty liver requires professional neuroimaging modalities or methods such as computed tomography, ultrasound, and medical experts' practical experiences. Considering this point, finding intelligent electronic noninvasive diagnostic approaches are desired at present. Currently, most existing works in the area of computerized noninvasive disease detection often apply one view (modality) or perform multi-view (several modalities) analysis, e.g., face, tongue, and/or sublingual for disease detection. The multi-view data of patients provides more complementary information for diagnosis. However, due to the conditions of data acquisition, interference by human factors, etc., many multi-view data are defective with some missing-view information, making these multi-view data difficult to evaluate. This factor largely affects the performance of classifying disease and the development of fully computerized noninvasive methods. Thus, the purpose of this study is to address the missing view issue among noninvasive disease detection. In this work, a multi-view dataset containing facial, sublingual vein, and tongue images are initially processed to produce corresponding feature for incomplete multi-view disease diagnostic evaluation. Hereby, we propose a novel method, i.e., multi-view completion, to process the incomplete multi-view data in order to complete the missing-view information for classifying fatty liver disease from healthy candidates. In particular, this method can explore the intra-view and inter-view information to produce the missing-view data effectively. Extensive experiments on a collected dataset with 220 fatty liver patients and 220 healthy samples show that our proposed approach achieves better diagnostic results with missing-view completion compared to the original incomplete multi-view data under various classifiers. Related results prove that our method can effectively process the missing-view issue and improve the noninvasive disease detection performance.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.compbiomed.2022.106097DOI Listing

Publication Analysis

Top Keywords

fatty liver
28
liver disease
20
disease detection
20
multi-view data
20
disease
12
noninvasive disease
12
incomplete multi-view
12
liver
10
multi-view
9
missing-view completion
8

Similar Publications

It is helpful for diagnostic purposes to improve our current knowledge of gut development and serum biochemistry in young piglets. This study investigated serum biochemistry, and gut site-specific patterns of short-chain fatty acids (SCFA) and expression of genes related to barrier function, innate immune response, antioxidative status and sensing of fatty and bile acids in suckling and newly weaned piglets. The experiment consisted of two replicate batches with 10 litters each.

View Article and Find Full Text PDF

Sodium Orthovanadate (SOV) mitigates alcohol & alcohol plus high-fat diet (HFD)-induced hepatotoxicity in rats.

Cell Mol Biol (Noisy-le-grand)

September 2025

Associate Professor, School of Pharmacy, Desh Bhagat University, Mandi Gobindgarh-Punjab 147301, India.

Alcoholic fatty liver disease (AFLD) is a leading cause of chronic liver disease worldwide, contributing to significant morbidity and mortality. Despite its growing prevalence, no FDA-approved pharmacological treatments exist, leaving lifestyle modifications as the primary intervention. AFLD pathogenesis involves a complex interplay of lipid accumulation, oxidative stress, insulin resistance, and inflammation, highlighting the need for innovative therapeutic approaches.

View Article and Find Full Text PDF

Metabolic associated steatohepatitis (MASH) is a severe form of metabolic dysfunction-associated steatotic liver disease (MASLD) characterized by hepatocellular injury, inflammation, and fibrosis. Despite advances in understanding its pathophysiology, the molecular mechanisms driving MASH progression remain unclear. This study investigates the role of long non-coding RNA Linc01271 in MASLD/MASH pathogenesis, ant its involvement in the miR-149-3p/RAB35 axis and PI3K/AKT/mTOR signaling pathway.

View Article and Find Full Text PDF

Background: The Middle East and North Africa (MENA) region is undergoing demographic shifts potentially increasing metabolic dysfunction-associated steatotic liver disease (MASLD) and its complications. We assessed MASLD prevalence and liver disease burden from 2010 to 2021.

Methods: Data from Global Burden of Disease (GBD), United Nations Population Division and NCD Risk Factor Collaboration covering 21 MENA countries were used for annual percent change (APC) trends per Joinpoint regression.

View Article and Find Full Text PDF

Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is an emerging global health concern, and its presence increases the risk of multi-system diseases. This study aimed to investigate the multimorbidity trajectories of chronic diseases in people living with MASLD.

Methods: We identified 137 859 MASLD patients in UK Biobank and used 'propensity score matching' to match an equal number of non-MASLD controls.

View Article and Find Full Text PDF